Development of a Conditional Replication System Using a Lassa Virus Glycoprotein Complex-Encoding Retroviral Vector for Isolating Resistant Variants to Inhibitors in BSL-2
Manya Bakatumana Hans, Anita Moendat Fanto, Tsutomu Fukuda, Koushirou Suga, Masatomo Iwao, Hideki Hayashi, Masaru Yokoyama, Hironori Sato, Olivier Tshiani Mbaya, Osamu Kotani, Yoshinao Kubo
TL;DR
Scientists created a safe system to study Lassa virus in lower biosafety labs and found mutations that make the virus resistant to treatments.
Contribution
A novel BSL-2 retroviral vector system for isolating Lassa virus glycoprotein complex variants resistant to inhibitors.
Findings
A retroviral vector encoding Lassa virus glycoprotein complex (GPC) was developed for replication in BSL-2 conditions.
Lassa virus GPC variants resistant to lamellarin α 20-sulfate and a neutralizing antibody were successfully isolated.
Specific amino acid substitutions (K125E, H13R, I403T) conferred resistance and altered infectivity or antibody binding.
Abstract
A high-risk infectious disease or a Category A pathogen, Lassa virus (LASV), requires strict containment, classified as biosafety level 4 (BSL-4) conditions, which restricts research on the virus due to the scarcity of BSL-4 facilities. Thus, replication-defective pseudotyped retroviral vectors have been widely used as safe materials for neutralizing activity assays of drugs and antibodies in BSL-2. Here, we established a novel retroviral vector system encoding LASV glycoprotein complex (GPC) that can exclusively replicate in cells expressing the Gag-Pol protein of murine leukemia virus (MLV) under BSL-2 conditions. Using this conditional replication system, we successfully isolated LASV GPC variants resistant to either an anti-LASV compound, lamellarin α 20-sulfate, or a neutralizing antibody derived from a Lassa fever survivor. In the lamellarin α 20-sulfate-resistant variants, K125E…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsViral Infections and Outbreaks Research · vaccines and immunoinformatics approaches · Mosquito-borne diseases and control